Company Description

Icosagen is a unique European CRDMO, being successfully in the business for more than 26 years as an independent family-owned company. As such, they combine pre-clinical CRO and clinical CDMO development expertise at one single site for therapeutic antibodies, multispecifics, ADCs, and other complex recombinant protein drug candidates.